Euroopa Liit - eesti - EMA (European Medicines Agency)

pfizer limited - sunitiniib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastilised ained - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Eesti - eesti - Ravimiamet

menarini international operations luxembourg s.a. - torasemiid - tablett - 5mg 100tk; 5mg 30tk; 5mg 50tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 25mg 110tk; 25mg 28tk; 25mg 56tk; 25mg 30tk; 25mg 100tk; 25mg 90tk; 25mg 70tk; 25mg 98tk; 25mg 84tk

Eesti - eesti - Ravimiamet

amomed pharma gmbh - naltreksoon - õhukese polümeerikattega tablett - 50mg 28tk; 50mg 7tk; 50mg 14tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 50mg 30tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 12,5mg 30tk

Eesti - eesti - Ravimiamet

menarini international operations luxembourg s.a. - torasemiid - tablett - 10mg 30tk; 10mg 50tk; 10mg 100tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 37,5mg 84tk; 37,5mg 30tk; 37,5mg 56tk; 37,5mg 28tk

Eesti - eesti - Ravimiamet

teva b.v. - sunitiniib - kõvakapsel - 50mg 28tk; 50mg 30tk

Eesti - eesti - Ravimiamet

teva b.v. - sorafeniib - õhukese polümeerikattega tablett - 200mg 112tk